ASEAN healthcare intelligence and deal flow

Healthcare in Southeast Asia remains under‑covered, and under‑capitalised as a consequence.

Reporting on the capital, the regulation and the science. Free to read.

  • Providers
  • Diagnostics
  • Medtech
  • Digital health
  • Pharma
  • Life sciences

What we publish

The Frontier is a free-to-read publication, open to all who want to follow healthcare in the region. Starting with Singapore and Malaysia, we track where the deals flow.

Deals and operators

Fundraising, acquisitions and listings, and the operators expanding behind them.

Regulation and reimbursement

Approval pathways, licensing requirements, and the schemes that determine payment.

Science and pipelines

Clinical progress, regulatory clearance, and the route to market.

Get the briefings in your inbox

For founders, operators and investors working in Southeast Asian healthcare.

Share a deal

Companies raising capital, seeking a buyer or looking for a partner in healthcare are invited to write to us.

Email deals@thefrontier.health

About

The Frontier is a publication, not an investor or adviser. Its people may back or work with businesses that appear in our briefings; any such interest is disclosed alongside the coverage.

The Frontier is free to read. Its purpose is to draw capital and attention toward healthcare in this region, not to generate subscription revenue.

Work with us

We are looking for researchers and editors. Full-time or freelance.

Research analyst

Track companies, deals and regulatory change across the region, and turn it into analysis readers can use.

Apply by email

Editor

Shape the briefings, hold the bar on accuracy and clarity, and build the publication's voice.

Apply by email